[º¸°ÇŸÀÓÁî] ÇѾç´ëÇб³º´¿ø(¿øÀå ÀÌÇüÁß)Àº ¿À´Â 6¿ù 23ÀÏ ÇѾç´ëÇб³ ÀÇ°ú´ëÇÐ º»°ü 6Ãþ TBL·ë¿¡¼ ´ëÇÑÀ̽ÄÇÐȸ¿Í °øµ¿À¸·Î ‘Àå±âÀÌ½Ä 1000·Ê ±â³ä °øµ¿ ½ÉÆ÷Áö¾ö’À» °³ÃÖÇÑ´Ù.
À̹ø ½ÉÆ÷Áö¾öÀº ¼¼ °³ÀÇ ¼¼¼ÇÀ¸·Î ±¸¼ºµÆÀ¸¸ç, Á¦1 ¼¼¼Ç ‘ÇѾç´ëÇб³º´¿ø ½ÅÀåÀÌ½Ä ¹× °£ÀÌ½Ä 1000·Ê ±â³ä’¿¡¼´Â ±Ç¿ÀÁ¤ ¸í¿¹±³¼ö¿Í ÀÌ°æ±Ù ±³¼ö(ÇѾç´ëÇб³º´¿ø ¿Ü°ú)°¡ ÁÂÀåÀ» ¸Ã°í, ÃÖÁöÀ± ±³¼ö(ÇѾç´ëÇб³º´¿ø ¿Ü°ú)°¡ ‘ÇѾç´ëÇб³º´¿ø ½ÅÀåÀ̽ÄÀÇ ¹ßÀü»ç’, ±è°æ½Ä ±³¼ö(ÇѾç´ëÇб³º´¿ø ¿Ü°ú)°¡ ‘ÇѾç´ëÇб³º´¿ø °£À̽ÄÀÇ ¹ßÀü»ç’¸¦ ÁÖÁ¦·Î °ÁÂÇÑ´Ù.
Á¦2 ¼¼¼Ç ‘Current issue in Organ transplantation’¿¡¼´Â ÃÖ±Ô¼º ±³¼ö(»ï¼º¼¿ïº´¿ø ¿Ü°ú)¿Í ÀÌÃ¢È ±³¼ö(ÇѾç´ëÇб³º´¿ø ½ÅÀå³»°ú)°¡ ÁÂÀåÀ» ¸Ã°í, ÃÖ¿µ·Ï ±³¼ö(¼¿ï´ëº´¿ø)°¡ ‘Application of ICG fluorescence images in liver transplantation’, Á¶Âù¿ì ±³¼ö(¿µ³²´ëº´¿ø)°¡ ‘Laparoscopic donor hepatectomy in living liver donor with the portal vein anomaly’, ¹ÚÁؼº ±³¼ö(ÇѾç´ëÇб³º´¿ø ½ÅÀå³»°ú)°¡ ‘Expanding kidney donor pool’, À¯¹Ì¿¬ ±³¼ö(ÇѾç´ëÇб³±¸¸®º´¿ø ½ÅÀå³»°ú)°¡ ‘Optimizing through level and intrapatient variability of Tacrolimus’¸¦ ÁÖÁ¦·Î °ÁÂÇÑ´Ù.
Á¦3 ¼¼¼Ç ‘Advances in Organ transplantation’¿¡¼´Â ±è±âÈÆ ±³¼ö(¼¿ï¾Æ»êº´¿ø)¿Í ¾çö¿ì ±³¼ö(¼¿ï¼º¸ðº´¿ø)°¡ ÁÂÀåÀ» ¸Ã°í, ±ÇÇö¿í ±³¼ö(¼¿ï¾Æ»êº´¿ø)°¡ ‘Exploring Kidney Transplants: Simultaneous and Sequential with Liver and Pancreas’, ¹ÚÀç¹ü ±³¼ö(»ï¼º¼¿ïº´¿ø)°¡ ‘Tolerance induction in kidney transplantation via CKBMT’, Á¤µ¿È¯ ±³¼ö(¼¿ï¾Æ»êº´¿ø)°¡ ‘The Review of Living Liver Donor Selection: Important factors for donor safety’, ÁÖµ¿Áø ±³¼ö(¼¼ºê¶õ½ºº´¿ø)°¡ ‘Machine perfusion: What's new?’¸¦ ÁÖÁ¦·Î °ÁÂÇÑ´Ù.
ÃÖµ¿È£ Àå±âÀ̽ļ¾ÅÍÀå(ÇѾç´ëÇб³º´¿ø ¿Ü°ú)Àº “º»¿ø Àå±âÀ̽ļ¾ÅÍ´Â ±¹³» ÃÖÃÊ ³ú»çÀÚ ½ÅÀåÀÌ½Ä ¼º°ø µî ±¹³» Àå±âÀÌ½Ä ¹ßÀü¿¡ Ãʼ®À» ´ÙÁ®¿Ô´Ù”¸é¼ “¾ÕÀ¸·Îµµ ÃÖ÷´Ü ±â¼úÀ» ¹ÙÅÁÀ¸·Î ±¹³»¸¦ ´ëÇ¥ÇÏ´Â Àå±âÀ̽ļ¾ÅÍ·Î °Åµì³ª±æ À§ÇØ ÃÖ¼±À» ´ÙÇÏ°Ú´Ù”¶ó°í ¸»Çß´Ù.
ÇÑÆí ¿¬¼ö°Á´ ´ëÇÑÀÇ»çÇùȸ ¿¬¼öÆòÁ¡ 2Á¡ÀÌ ÁÖ¾îÁö¸ç, °Á¿¡ ´ëÇÑ ÀÚ¼¼ÇÑ ³»¿ëÀº Àå±âÀ̽ļ¾ÅÍ·Î ¹®ÀÇÇÏ¸é µÈ´Ù.(T. 02-2290-8865)